Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag

  • Jian Tai Qiu*
  • , Ting Chang Chang
  • , Cheng Tao Lin
  • , Yi Ming Chen
  • , Frank Q. Li
  • , Yung Kuei Soong
  • , Chyong Huey Lai
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

35 Scopus citations

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a potent immunomodulatory cytokine. Here we generated a novel codon-optimized murine GM-CSF gene as an adjuvant. The codon-optimized GM-CSF gene significantly increased protein expression levels in all cells tested. Although injection of the wild-type GM-CSF plasmids adjuvanted HIV-1 Gag DNA vaccine induced detectable immune responses, co-administration of plasmids encoding the codon-optimized GM-CSF sequence with the DNA vaccine resulted in a strong antibody and CTL responses and a protective immune response against infection with recombinant vaccinia virus expressing HIV-1 Gag. This novel codon-optimized GM-CSF gene offers a practical molecular strategy for potentiating immune responses to vaccines as well as other immunotherapeutic strategies.

Original languageEnglish
Pages (from-to)253-263
Number of pages11
JournalVaccine
Volume25
Issue number2
DOIs
StatePublished - 04 01 2007
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • DNA vaccine
  • GM-CSF
  • HIV-1
  • Immunity
  • T-lymphocytes

Fingerprint

Dive into the research topics of 'Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag'. Together they form a unique fingerprint.

Cite this